Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018
JOURNAL OF RHEUMATOLOGY, vol.46, no.9, pp.1198-1201, 2019 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 46 Issue: 9
- Publication Date: 2019
- Doi Number: 10.3899/jrheum.181072
- Journal Name: JOURNAL OF RHEUMATOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1198-1201
- Keywords: VASCULITIS, TAKAYASU ARTERITIS, GIANT CELL ARTERITIS, LARGE-VESSEL VASCULITIS, OUTCOMES, OMERACT, QUALITY-OF-LIFE, GIANT-CELL ARTERITIS, DISEASE-ACTIVITY, TAKAYASUS-ARTERITIS, ACTIVITY SCORE, HEALTH
- Istanbul University Affiliated: Yes
Abstract
Objective. The Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group seeks to develop validated outcome measures for use in trials for large-vessel vasculitis (LVV).